The global sotalol market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Sotalol, a methane sulfonamide, is a class III antiarrhythmic drug that belongs to a group of medicines called beta-blockers and is used for the treatment of atrial fibrillation and other conditions that cause an irregular heartbeat (arrhythmia). It is used to support keep the heart beating normally. The major factor driving the demand for sotalol is the increasing incidence of atrial fibrillation across the globe.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/sotalol-market
According to the American Heart Association report, atrial fibrillation is a common heart arrhythmia in adults with approximately 1 in 4 adults over the age of 40 years developing AFib1. Furthermore, as per the same source, it is estimated that nearly $6 billion is spent on AFib hospitalizations in the US each year. Hence, the increasing prevalence of cardiac arrest is driving the demand for sotalol for treatment as it stabilizes the heartbeat which in turn is driving the growth of the market. However, the growth of the market is hampered due to the side effects associated with sotalol such as blurred vision, chest pain, tightness or discomfort, confusion, difficult or labored breathing, among others.
Inquire for Discount on this Report at
https://www.omrglobal.com/report-customization/sotalol-market
Some major players in the market include Bayer AG, GlaxoSmithKline plc, and Bristol-Myers Squibb, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2020, AltaThera Pharmaceuticals, LLC announced the approval of a new indication for Sotalol IV in AFib patients from the US Food and Drug Administration (FDA).
Competitive Landscape- Bayer AG, GlaxoSmithKline plc, and Bristol-Myers Squibb, among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Sotalol Market Report by Segment
By Type
40 Mg
80 Mg
By Application
Sustained Ventricular Tachycardia
Atrial Fibrillation
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404